← Back to Discover
Novo Holdings A/S
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,722,216,880
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- EDGEWISE THERAPEUTICS INC · COM · 28036F105 · shares: $217,370,500
- ASML HOLDING N V · N Y REGISTRY SHS · N07059210 · shares: $188,889,370
- HEMAB THERAPEUTICS HLDGS INC · COM SHS · 423494103 · shares: $153,551,602
- BROOKFIELD CORP · CL A LTD VT SH · 11271J107 · shares: $149,534,399
- MAPLIGHT THERAPEUTICS INC · COM · 56565P103 · shares: $132,128,532
- MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $131,703,750
- AVALYN PHARMACEUTICALS INC · COM SHS · 05348Y105 · shares: $127,837,874
- SALESFORCE INC · COM · 79466L302 · shares: $61,596,675
- ARRIVENT BIOPHARMA INC · COM · 04272N102 · shares: $52,110,000
- ENLIVEN THERAPEUTICS INC · COM · 29337E102 · shares: $50,750,000
Reported holdings
25 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 5,350,000 shares | $217,370,500 |
| ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | — | 94,946 shares | $188,889,370 |
| HEMAB THERAPEUTICS HLDGS INC | COM SHS | 423494103 | — | 4,180,550 shares | $153,551,602 |
| BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | — | 3,496,245 shares | $149,534,399 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 3,686,622 shares | $132,128,532 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 1,125,000 shares | $131,703,750 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 3,883,289 shares | $127,837,874 |
| SALESFORCE INC | COM | 79466L302 | — | 393,187 shares | $61,596,675 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | — | 1,500,000 shares | $52,110,000 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 1,000,000 shares | $50,750,000 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 1,320,000 shares | $49,394,400 |
| PHARVARIS N V | COM | N69605108 | — | 1,400,000 shares | $48,412,000 |
| FLOOR & DECOR HLDGS INC | CL A | 339750101 | — | 797,000 shares | $47,309,920 |
| VAXCYTE INC | COM | 92243G108 | — | 800,000 shares | $46,504,000 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 3,249,178 shares | $43,214,067 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 2,135,000 shares | $39,219,950 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 1,025,000 shares | $38,140,250 |
| ALUMIS INC | COM | 022307102 | — | 1,100,000 shares | $30,954,000 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 485,438 shares | $29,301,038 |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | — | 257,327 shares | $24,698,245 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 960,394 shares | $21,330,351 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | — | 2,250,000 shares | $17,145,000 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 120,723 shares | $12,871,486 |
| MARQETA INC | CLASS A COM | 57142B104 | — | 441,558 shares | $7,170,902 |
| LANZATECH GLOBAL INC | COM NEW | 51655R200 | — | 158,148 shares | $1,078,569 |